Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001681:Biological Assay; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003404:Creatinine / Q000652:urine; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007700:Kinetics; D008875:Middle Aged; D006435:Renal Dialysis; D013210:Staphylococcus; D013440:Sulfides / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D013777:Tetrazoles / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D013830:Thiadiazoles / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D013997:Time Factors; D014511:Uremia / Q000378:metabolism* / Q000628:therapy
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D003404:Creatinine